Lanean...

Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?

BACKGROUND AND AIM: Currently, sorafenib is indicated for hepatocellular carcinoma (HCC) with extrahepatic metastasis (EHM), and many other systemic agents are becoming available. However, a few HCC patients with EHM still undergo transarterial chemoembolization (TACE) for intrahepatic tumor control...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Kim, Jihye, Sinn, Dong-Hyun, Choi, Moon Seok, Kang, Wonseok, Gwak, Geum-Youn, Paik, Yong-Han, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2019
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6405107/
https://ncbi.nlm.nih.gov/pubmed/30845192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0213547
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!